摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-chloroacetyl-2-(2-chloro-ethylamino)-[1,3,2]oxazaphosphinane (R)-2-oxide | 72578-71-3

中文名称
——
中文别名
——
英文名称
3-chloroacetyl-2-(2-chloro-ethylamino)-[1,3,2]oxazaphosphinane (R)-2-oxide
英文别名
(R)-2-Chloro-1-(2-((2-chloroethyl)amino)-2-oxido-1,3,2-oxazaphosphinan-3-yl)ethanone;2-chloro-1-[(2R)-2-(2-chloroethylamino)-2-oxo-1,3,2λ5-oxazaphosphinan-3-yl]ethanone
3-chloroacetyl-2-(2-chloro-ethylamino)-[1,3,2]oxazaphosphinane (<i>R</i>)-2-oxide化学式
CAS
72578-71-3
化学式
C7H13Cl2N2O3P
mdl
——
分子量
275.072
InChiKey
KJRISYCCYWZCOF-OAHLLOKOSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    355.0±52.0 °C(Predicted)
  • 密度:
    1.42±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.8
  • 重原子数:
    15
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.86
  • 拓扑面积:
    58.6
  • 氢给体数:
    1
  • 氢受体数:
    4

SDS

SDS:69a9b912588d2d770ff8ea05e355f8d7
查看

制备方法与用途

用途 
异环磷酰胺中间体

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Ifosfamide, analogues thereof and their preparation
    申请人:——
    公开号:US20020052521A1
    公开(公告)日:2002-05-02
    The present invention pertains to a compound of formula (I) 1 wherein R 1 and R 2 are each (CH 2 ) m X, each X is Cl or Br and m is 2 or 3, in combination with less than 0.5% w/w of the corresponding compound wherein R 1 is (CH 2 ) m H. Such compounds can be prepared by (i) the reaction of a Bronsted acid or a Lewis acid with NaBH 4 in an organic solvent, and (ii) adding the resultant solution to a solution of a corresponding compound wherein one of R 1 and R 2 is CO(CH 2 ) n X and the other is CO(CH 2 ) n X or (CH 2 ) m X, wherein n=m−1. Such compounds can also be prepared, in optically-enriched form, starting from an optically-enriched trihaloiminophosphorane of the formula R*N=Phal 3 wherein NR* is a chiral moiety derivable from a chiral amine or chiral sulphonamide of the formula R*NH 2 , which can be cyclisable with HO(CH 2 ) 3 NHR.
    本发明涉及一种式(I)的化合物,其中R1和R2均为(CH2)mX,每个X为Cl或Br,m为2或3,与相应化合物中R1为( )mH的化合物相比,其含量小于0.5% w/w。这些化合物可以通过以下步骤制备:(i)用有机溶剂反应Bronsted酸或Lewis酸与NaBH4;(ii)将所得溶液加入其中一个R1和R2分别为CO( )nX和CO( )nX或( )mX的相应化合物的溶液中,其中n=m-1。这些化合物也可以以光学纯形式制备,其起始物为式R*N=Phal3的光学纯三卤代亚酰胺,其中NR*是可由手性胺或手性磺酰胺的式R*NH2衍生的手性基团,可与HO( )3NHR环化。
  • IFOSFAMIDE, ANALOGUES THEREOF AND THEIR PREPARATION
    申请人:Darwin Discovery Limited
    公开号:EP0876381A1
    公开(公告)日:1998-11-11
  • [EN] IFOSFAMIDE, ANALOGUES THEREOF AND THEIR PREPARATION<br/>[FR] IFOSFAMIDE, ANALOGUES DE LADITE SUBSTANCE ET LEUR PREPARATION
    申请人:DARWIN DISCOVERY LIMITED
    公开号:WO1997022614A1
    公开(公告)日:1997-06-26
    (EN) A compound of formula (I) wherein R1 and R2 are each (CH2)mX, R3 is H, each X is Cl or Br and m is 2 or 3, in combination with less than 0.5 % w/w of the corresponding compound wherein R1 is (CH2)mH. Such compounds can be prepared by (i) the reaction of a Bronsted acid or a Lewis acid with NaBH4 in an organic solvent, and (ii) adding the resultant solution to a solution of a corresponding compound wherein one of R1 and R2 is CO(CH2)nX and the other is CO(CH2)nX or (CH2)mX, wherein n = m-1. Such compounds can also be prepared, in optically-enriched form, starting from an optically-enriched trihaloiminophosphorane of the formula R*N = Phal3 wherein NR* is a chiral moiety derivable from a chiral amine or chiral sulphonamide of the formula R*NH2, which can be cyclisable with HO(CH2)3NHR.(FR) Composé de formule (I) dans laquelle R1 et R2 sont chacun (CH2)mX, R3 est H, chaque X est Cl ou Br et m est 2 ou 3, en combinaison avec moins de 0,5 % en poids du composé correspondant dans lequel R1 est (CH2)mH. Ces composés peuvent être préparés par (i) réaction d'un acide de Bronsted ou d'un acide de Lewis avec NaBH4 dans un solvant organique et (ii) par ajout de la solution qui en résulte à une solution d'un composé correspondant, R1 ou R2 étant l'un CO(CH2)nX et l'autre CO(CH2)nX ou (CH2)mX, n étant égal à m-1. Lesdits composés peuvent également être préparés, sous une forme optiquement enrichie, à partir d'un trihalo-iminophosphorane optiquement enrichi de formule R*N = Phal3, dans laquelle NR* est une fraction chirale pouvant être dérivée d'une amine chirale ou d'un sulphonamide chiral de formule R*NH2, qui peut constituer un cycle avec HO(CH2)3NHR.
查看更多

同类化合物

曲磷胺 曲磷胺 异环磷酰胺杂质F 异环磷酰胺 [(2-羟基-2-氧代-1,4,2-氧氮杂磷杂环己烷-4-基)甲基]膦酸 4-过氧化氢异环磷酰胺 4-氧代异环磷酰胺 4-乙基-7-甲基-7-氮杂-2,6-二氧杂-1-磷杂双环[2.2.2]辛烷1-硫化物 2’-氧代异环磷酰胺 2-[2-氯乙基-[3-(2-氯乙基)-2-氧代-1-氧杂-3-氮杂-2-磷杂环己-2-基]氨基]乙基甲烷磺酸酯 2,3,4,6,7,8-六氢-[1,3,2]氧氮杂膦咛并[2,3-b][1,3,2]氧氮杂膦咛 (2-氯-乙基)-[(R)-3-(2-氯-乙基)-2-氧代-2lambda5-[1,3,2]氧氮杂磷杂环己烷-2-基]-胺 (S)-2-Chloro-4-isobutyl-[1,3,2]oxazaphospholidine 2-sulfide (SCRP)-2-anilino-3-(α-methylbenzyl)-1,3,2λ5-oxazaphosphorinane 2-oxide 2-Chlor-1-(β-chlorethylamino)-1,3,2-azaoxaphosphorinan (SCSP)-2-anilino-3-(α-methylbenzyl)-1,3,2λ5-oxazaphosphorinane 2-oxide 2-[4-(2-Piperidin-1-yl-ethyl)-piperazin-1-yl]-[1,3,2]oxazaphosphinane 2-oxide (5-tert-Butyl-3-phenyl-[1,3,2]oxazaphosphinan-2-yl)-dimethyl-amine 4-Hydroperoxyisophosphamid-6-14C (E)-3-tert-butyl-6,6-dimethyl-2-oxo-[2'-((E)-2-butenyloxy)-1'-butenyl]-1,3,2-oxazaphosphorinane trichloroethyl cyclophosphoramidate 2(S)--3-<(R)-α-methylbenzyl>-1,3,2-oxazaphosphorinane 2-oxide 3-sec-Butyl-2-(2-chloro-ethylsulfanyl)-[1,3,2]oxazaphosphinane 2-oxide 3-sec-Butyl-2-(2-chloro-propylsulfanyl)-6-methyl-[1,3,2]oxazaphosphinane 2-oxide 3-sec-Butyl-2-(2-chloro-propylsulfanyl)-[1,3,2]oxazaphosphinane 2-oxide 2(S)--3-<(S)-α-methylbenzyl>-1,3,2-oxazaphosphorinane 2-oxide 3-sec-Butyl-2-(2-chloro-ethylsulfanyl)-6-methyl-[1,3,2]oxazaphosphinane 2-oxide 3-sec-Butyl-2-(2-chloro-1-methyl-propoxy)-[1,3,2]oxazaphosphinane 2-sulfide 2-hexadecyloxy-3-methyl-[1,3,2]oxazaphosphinane 2-oxide cis-4-Hydroperoxytrofosfamide 2(S)--3-<(R)-α-methylbenzyl>-1,3,2-oxazaphosphorinane 2-oxide 2H-1,3,2-Oxazaphosphorin-2-amine,N,N-diethyltetrahydro-3-(phenylmethyl)- 3-sec-Butyl-2-(2-chloro-1-methyl-ethoxy)-[1,3,2]oxazaphosphinane 2-sulfide cis-2-methoxy-2-thio-5-tert-butyl-1,3,2-oxazaphosphorinane 3,7,10-trimethyl-1-phenylgermatrane 2-{(2-Chloro-ethyl)-[3-(2-chloro-ethyl)-2-oxo-2λ5-[1,3,2]oxazaphosphinan-2-yl]-amino}-ethanol 3-benzyl-2-chloro-[1,3,2]oxazaphosphinane 2-(O,O-Di-n-propyl-phosphordithiomethylen)-2-methyl-1,3-oxazolidin cis-2,3-diphenyl-2-oxo-5-tert-butyl-1,3,2λ5-oxazaphosphorinane 2-ethoxy-[1,3,2]oxazaphosphinane 2-oxide 1-Acetyl-2-diaethylamino-1,3,2-azaoxaphosphorinan 1,5-dioxa-2,6-dioxo-2,4,4,6,8,8-hexakis(pyrrolidino)cyclotetraphosphadiazadiene (2,4-dimethyl-2-oxo-2λ5-[1,3,2]oxazaphosphinan-3-yl)-phosphonous acid bis-diethylamide 2,6,6,9,12,12-hexamethyl-3,10-diphenyl-1,8-dioxa-4,11-dithia-2,9-diaza-dispiro[4.1.4.1]dodecane 2-isopropoxy-[1,3,2]oxazaphosphinane 2-sulfide 2-thioxo-2λ5-[1,3,2]oxazaphosphinan-2-ylamine (2R,3S,5S)-2,3,5-triphenyl-2-oxo-[1,4,2]-oxazaphosphinane 2-propoxy-[1,3,2]oxazaphosphinane 2-(diethylthiocarbamoylthio)-3-phenyl-1,3,2-oxazaphospholidine